P3.15-005 Third Line Chemotherapy in SCLC: The West of Scotland Experience

Scotland has one of the highest incidences of SCLC globally (cancerresearchuk.org). Lung cancer is the leading cause of cancer related deaths in the UK (cancerresearchuk.org), with SCLC having a worse prognosis than NSCLC and fewer treatment options. Initially, SCLC has a high response rate to first line chemotherapy but rapidly becomes resistant to chemotherapy. There is little evidence to support and guide third line chemotherapy regimens. A West of Scotland (WoS) retrospective database (2007 to 2013) has been developed to gain useful insights into this aggressive disease to improve patient outcomes.